These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 4625628
1. Cross-resistance of Pseudomonas to gentamicin and tobramycin. Brusch JL, Barza M, Bergeron MG, Weinstein L. Antimicrob Agents Chemother; 1972 Mar; 1(3):280-1. PubMed ID: 4625628 [Abstract] [Full Text] [Related]
3. Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate. Traub WH, Raymond EA. Appl Microbiol; 1972 Jan; 23(1):4-7. PubMed ID: 4621796 [Abstract] [Full Text] [Related]
5. Comparative study of tobramycin and gentamicin with special reference to anti-pseudomonas activity. Klastersky J, Daneau D, de Maertelaer V. Clin Pharmacol Ther; 1973 Jan; 14(1):104-11. PubMed ID: 4630232 [No Abstract] [Full Text] [Related]
6. Tobramycin: bacteriological evaluation. Burger LM, Sanford JP, Zweighaft T. Am J Med Sci; 1973 Feb; 265(2):135-42. PubMed ID: 4196741 [No Abstract] [Full Text] [Related]
7. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides. Watanakunakorn C, Kauffman CA. Infection; 1978 Feb; 6(3):111-5. PubMed ID: 98451 [Abstract] [Full Text] [Related]
8. [Tobramycin-gentamicin: the To-Ge pretext of aminoside antibiotics]. Morel C, Freymuth F. Nouv Presse Med; 1973 Jan 27; 2(4):246. PubMed ID: 4568329 [No Abstract] [Full Text] [Related]
11. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study. Phillips I, King A, Shannon K. Am J Med; 1986 Jun 30; 80(6B):48-55. PubMed ID: 3728534 [Abstract] [Full Text] [Related]
12. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)]. Schassan HH. Infection; 1976 Jun 30; 4(2):35-41. PubMed ID: 789246 [Abstract] [Full Text] [Related]
13. Susceptibility of nonfermentative gram-negative bacilli to tobramycin. Uwaydah M, Taqi-Eddin AR. J Infect Dis; 1976 Aug 30; 134 Suppl():S28-32. PubMed ID: 823278 [Abstract] [Full Text] [Related]
14. The in-vitro activity of tobramycin compared with that of other aminoglycosides. Waterworth PM. J Clin Pathol; 1972 Nov 30; 25(11):979-83. PubMed ID: 4648543 [Abstract] [Full Text] [Related]
15. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species. Ducan IB, Penner JL. Can Med Assoc J; 1975 Jul 12; 113(1):29-31. PubMed ID: 807310 [Abstract] [Full Text] [Related]
16. Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism. Zimelis VM, Jackson GG. J Infect Dis; 1973 Jun 12; 127(6):663-9. PubMed ID: 4196445 [No Abstract] [Full Text] [Related]
17. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Kluge RM, Standiford HC, Tatem B, Young VM, Greene WH, Schimpff SC, Calia FM, Hornick RB. Antimicrob Agents Chemother; 1974 Oct 12; 6(4):442-6. PubMed ID: 4157342 [Abstract] [Full Text] [Related]
18. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas. Murray PR. Antimicrob Agents Chemother; 1980 Mar 12; 17(3):474-6. PubMed ID: 6252830 [Abstract] [Full Text] [Related]
19. The effect of tobramycin on Pseudomonas keratitis. Smolin G, Okumoto M, Wilson FM. Am J Ophthalmol; 1973 Oct 12; 76(4):555-60. PubMed ID: 4200625 [No Abstract] [Full Text] [Related]